J07BB02 influenza, inactivated, split virus or surface antigen
J ANTIINFECTIVES FOR SYSTEMIC USE
J07BB02 influenza, inactivated, split virus or surface antigen
Medicines by ATC code J07BB02 influenza, inactivated, split virus or surface antigen
- Flucelvax Tetra Patient leaflet Summary of medicine characteristics
- Supemtek Patient leaflet Summary of medicine characteristics
- Fluad Tetra Patient leaflet Summary of medicine characteristics
- Aflunov Patient leaflet Summary of medicine characteristics
- Foclivia Patient leaflet Summary of medicine characteristics
- Prepandrix Patient leaflet Summary of medicine characteristics
- Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) Patient leaflet Summary of medicine characteristics
- Intanza Patient leaflet Summary of medicine characteristics
- IDflu Patient leaflet Summary of medicine characteristics
- Optaflu Patient leaflet Summary of medicine characteristics
- Pandemrix Patient leaflet Summary of medicine characteristics
- Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Patient leaflet Summary of medicine characteristics
- Focetria Patient leaflet Summary of medicine characteristics
- Pumarix Patient leaflet Summary of medicine characteristics
- Prepandemic Influenza Vaccine (H5N1) (Split Virion, Inactivated, Adjuvanted) GlaxoSmithKline Biologicals Patient leaflet Summary of medicine characteristics
- Arepanrix Patient leaflet Summary of medicine characteristics
- Humenza Patient leaflet Summary of medicine characteristics